IACMI Celebrates Decade of Innovation, Economic Growth and Strengthening U.S. Advanced Manufacturing
Established by the Department of Energy in 2015, IACMI has emerged as a leader in advanced composites and workforce solutions, bolstering American manufacturing and national defense KNOXVILLE, Tenn., Jan. 9, 2025 /PRNewswire/ — The Institute for Advanced Composites Manufacturing Innovation®
Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS
SOUTH SAN FRANCISCO, Calif., Jan. 9, 2025 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to R2
Gene Therapy Pioneer Jim Wilson Comments on iECURE’s Announcement of Complete Clinical Response for ECUR-506
“This illustrates the amazing power of modern day science and the importance of persistence.” PHILADELPHIA, Jan. 9, 2025 /PRNewswire/ — Today, Dr. Jim Wilson, President and CEO of GEMMA Biotherapeutics (“GEMMABio”) and co-founder of iECURE commented on the company’
Olivine, music and bubbles: a new method to remove CO2 in minutes
THE HAGUE, the Netherlands, Jan. 9, 2025 /PRNewswire/ — In a breakthrough that combines art, science and music, Dutch inventor Ap Verheggen has discovered a revolutionary method to combat climate change: removing CO2 from the air in minutes instead of decades. In partnership with startup exp
Sen-Jam Pharmaceutical Files Groundbreaking Patent for Novel Therapeutic Approach to Address Obesity and Metabolic Disorders
HUNTINGTON, N.Y., Jan. 9, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical, a leader in innovative anti-inflammatory care, today announced the submission of a new patent application that introduces a novel composition and method to target obesity and metabolic disorders. The patent focuses on lever
INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments
PLYMOUTH MEETING, Pa., Jan. 9, 2025 /PRNewswire/ — INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today highlighted anticipated milestones for 202
Everseen Partners With Google Cloud to Transform Physical Retail Store Operations with Vision AI
By partnering with Google Cloud, Everseen continues to scale its vision AI platform to help retailers reduce shrink, streamline operations and enhance customer experiences SUNNYVALE, Calif., Jan. 9, 2025 /PRNewswire/ — Ahead of NRF 2025, the retail industry’s largest event, Everseen toda
Mabwell’s Nectin-4 Targeted ADC 9MW2821 Combination Therapy Demonstrates 87.5% ORR and Granted CDE Breakthrough Therapy Designation
SHANGHAI, Jan. 9, 2025 /PRNewswire/ — Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced a significant milestone for its proprietary Nectin-4 targeted ADC (9MW2821). On January 8, 2025, 9MW2821 was granted Breakthrough Therapy Designation (BTD) b
BRImo Mobile Banking, a Worldwide Simplicity in Your Hand
JAKARTA, Indonesia, Jan. 9, 2025 /PRNewswire/ — PT Bank Rakyat Indonesia (BRI) Persero Tbk. (IDX: BBRI) presents the #BRImoWorldXperience, expanding BRImo’s cross-border capabilities. The super-app also reinforces BRI’s leadership in financial digitalization, with nearly 99% of tra
Biocon Biologics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
BRIDGEWATER, N.J., and BENGALURU, India, Jan. 9, 2025 /PRNewswire/ — Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), will present at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January
